
Gastalfet100 ml
Beximco Pharmaceuticals Ltd.
Sucralfate is a locally-acting mucosal protectant primarily indicated for gastrointestinal ulcer disease.
Sucralfate is a locally-acting mucosal protectant primarily indicated for gastrointestinal ulcer disease. Its evidence-based uses are classified as follows:
Use of Sucralfate for indications beyond active/maintenance duodenal ulcer therapy is generally considered off-label and should be guided by a physician's clinical judgment.
| Indication | Adult Dose |
|---|---|
| Active duodenal ulcer | 1 g four times daily, on an empty stomach, 1 hour before meals and at bedtime, for 4–8 weeks (or as directed by physician) |
| Maintenance therapy (duodenal ulcer) | 1 g twice daily |
| Stress ulcer prophylaxis / other off-label uses | As directed by the treating physician; regimens vary by indication and setting |
Sucralfate is generally very well tolerated because of its minimal systemic absorption. Reported adverse effects include:
Sucralfate is contraindicated in patients with known hypersensitivity to Sucralfate or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.